Daxor Corp (DXR) - NYSEMKT
  • Jun. 19, 2014, 1:40 PM
    • Daxor Corp's (DXR +3.7%) BOD votes to explore its strategic options including partnering with a larger company and/or a partial sale of the firm. It intends to engage an investment banker to expedite the process.
    • The BOD also authorizes the renewal of the company's stock repurchase program of up to 250K shares.
    | Jun. 19, 2014, 1:40 PM
Company Description
Daxor Corp. is a biotechnology company. The company's focus has been the creation and development of the BVA-100 blood volume analyzer, an instrument that rapidly and accurately measures human blood volume. Its IDANT division provides semen banking services, which include anonymous donor semen... More
Sector: Healthcare
Industry: Medical Instruments & Supplies
Country: United States